Petrelintide is an investigational clinical program.
Each answer stays attached to the compound identity and destination records. This is a verification guide, not medical or legal advice, a seller recommendation, or proof of availability.
Petrelintide is an investigational clinical program. No seller listing in Singapore can inherit the sponsor’s clinical identity, trial evidence, or regulatory status. Check any exact product and supplier claim in the destination records below.
Resolve the exact identity of Petrelintide through ZUPREME-1 Phase 2 study - NCT06662539 from ClinicalTrials.gov. Then search HSA Infosearch from Singapore Health Sciences Authority for the destination product record and Supply through e-pharmacy from Singapore Health Sciences Authority for the seller, establishment, or supply route in Singapore. A match in one record does not replace the other two checks.
No. A page using the name Petrelintide, local currency, a domestic delivery claim, or a familiar package image is only a lead. This is an investigational program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For Singapore, the exact product, presentation, seller identity, current record status, and claimed supply route must resolve through the official sources on this page.
The current registry snapshot contains no Petrelintide study record with a listed Singapore location. This is a dated search result, not proof that a study cannot be added later.
Registry update: 24 July 2026The current registry snapshot contains no Petrelintide study record with a listed Singapore location. This is a dated search result, not proof that a study cannot be added later.
ClinicalTrials.gov search ↗Petrelintide is an investigational clinical program. No seller listing in Singapore can inherit the sponsor’s clinical identity, trial evidence, or regulatory status. Check any exact product and supplier claim in the destination records below.
Primary identity source: ZUPREME-1 Phase 2 study - NCT06662539 / ClinicalTrials.gov ↗A credible result must keep these separate. The official links answer different questions and should be checked in sequence.
ZUPREME-1 Phase 2 study - NCT06662539 is maintained by ClinicalTrials.gov. Open the current record and match the exact name, holder, presentation, legal entity, status, or route relevant to the claim.
Open ZUPREME-1 Phase 2 study - NCT06662539 ↗HSA Infosearch is maintained by Singapore Health Sciences Authority. Open the current record and match the exact name, holder, presentation, legal entity, status, or route relevant to the claim.
Open HSA Infosearch ↗Supply through e-pharmacy is maintained by Singapore Health Sciences Authority. Open the current record and match the exact name, holder, presentation, legal entity, status, or route relevant to the claim.
Open Supply through e-pharmacy ↗Singapore's HSA publishes distinct records for therapeutic products, health-product dealers, poisons licences, retail pharmacies, and illegal health products. A clinic page, marketplace listing, supplement description, or Singapore domain does not resolve all of those checks.
The country guide supplies the local verification sequence. It does not convert an online listing into an authorized product or verified seller.
Use HSA Infosearch and the Register of Therapeutic Products to match the exact product, registration details, holder, and status rather than inferring authorization from an ingredient or overseas brand.
Search HSA's licensed importer, wholesaler, manufacturer, poisons-licence, and retail-pharmacy records for the legal entity behind the offer. Each register covers a different activity.
For electronic prescription supply, confirm the named platform appears with the licensed pharmacy and follows HSA's closed-loop prescription and local licensing requirements.
Open the live record and confirm its current status. A linked source begins the verification process; it does not mean Peptide Local authenticated a product or seller.